Genetic Signatures Limited (ASX: GSS)
Sector: Health Care
Market cap: A$18M (as of 2 Nov 2026)
Molecular Diagnostics.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 28 Sept 2026 | Mercer Investments (Australia) Limited as RE of Mercer Australian Small Companies Fund, Mercer Investments (Australia) Limited as RE of Mercer DG (ex p) Trust, Mercer Investments (Australia) Limited as Trustee of WSSP Australian Equities Trust | Entry | ?% → 5.15% | Filing ↗ |
| 27 Aug 2026 | Mercer Investments (Australia) Limited as RE of Mercer Australian Small Companies Fund, Mercer Investments (Australia) Limited as RE of Mercer DG (ex p) Trust, Mercer Investments (Australia) Limited as Trustee of WSSP Australian Equities Trust | Exit | ?% → 4.338% | Filing ↗ |
| 26 Aug 2026 | BCAL DIAGNOSTICS LIMITED and its subsidiaries, BCAL Diagnostics, Inc, Early Detection Australia Pty Limited, Early Detection (NZ) Limited | Increase | 10.2% → 18.46% | Filing ↗ |
| 25 Aug 2026 | Perennial Value Management Limited (PVM) | Decrease | 14.81% → 6.31% | Filing ↗ |
| 2 July 2026 | BCAL DIAGNOSTICS LIMITED and its subsidiaries, BCAL Diagnostics, Inc, Early Detection Australia Pty Limited, Early Detection (NZ) Limited | Entry | ?% → 10.2% | Filing ↗ |
Director trades — on-market
Cash and runway
Ask about GSS in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has GSS raised money in the last year, and at what discount?
- What was GSS's latest cash position and runway?
Loading GSS…